Show simple item record

dc.contributor.authorPrada Rico, Mayerly
dc.contributor.authorFernández Sarmiento, Jaime
dc.contributor.authorRojas Velasquez, Ana María
dc.contributor.authorGonzález Chaparro, Luz Stella
dc.contributor.authorGastelbondo Amaya, Ricardo
dc.contributor.authorMulett Hoyos, Hernando
dc.contributor.authorTibaduiza, Daniel
dc.contributor.authorQuintero Gómez, Ana Maria
dc.date.accessioned9/12/2019 10:50
dc.date.available2019-09-12T15:50:17Z
dc.date.issued2017
dc.identifier.citationRico, M.P., Fernández Sarmiento, J., Rojas Velasquez, A.M. et al. Pediatr Nephrol (2017) 32: 703. https://doi.org/10.1007/s00467-016-3544-9es_CO
dc.identifier.issn1432-198X
dc.identifier.otherhttps://link.springer.com/article/10.1007%2Fs00467-016-3544-9#citeas
dc.identifier.otherhttps://link.springer.com/content/pdf/10.1007%2Fs00467-016-3544-9.pdf
dc.identifier.urihttp://hdl.handle.net/10818/37145
dc.description9 páginases_CO
dc.description.abstractBackground Anticoagulation of the continuous renal replacement therapy (CRRT) circuit is an important technical aspect of this medical procedure. Most studies evaluating the efficacy and safety of citrate use have been carried out in adults, and little evidence is available for the pediatric patient population. The aim of this study was to compare regional citrate anticoagulation versus systemic heparin anticoagulation in terms of the lifetime of hemofilters in a pediatric population receiving CRRT at a pediatric center in Bogota, Colombia. Methods This was an analytical, observational, retrospective cohort study in which we assessed the survival of 150 hemofilters (citrate group 80 hemofilters, heparin group 70 hemofilters) used in a total of 3442 hours of CCRT (citrate group 2248 h, heparin group 1194 h). Hemofilter survival was estimated beginning at placement and continuing until filter replacement due to clotting or high trans-membrane pressures. Results Hemofilter survival was higher in the citrate group than in the heparin group (72 vs. 18 h; p <0.0001). Bivariate analysis showed that the hemofilter coagulation risk was significantly increased when heparin was used, regardless of hemofilter size and pump flow (hazard ratio 3.70, standard error 0.82, 95% confidence interval 2.39–5.72; p <0.00001). Conclusions Regional citrate anticoagulation could be more effective than heparin systemic anticoagulation in terms of prolonging the hemofilter lifetime in patients with acute renal injury who require CRRT.en
dc.formatapplication/pdfes_CO
dc.language.isoenges_CO
dc.publisherPediatric Nephrologyes_CO
dc.relation.ispartofseriesPediatr Nephrol (2017) 32: 703
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.sourceUniversidad de La Sabanaes_CO
dc.sourceIntellectum Repositorio Universidad de La Sabanaes_CO
dc.subjectAnticoagulationes_CO
dc.subjectCitratees_CO
dc.subjectHeparines_CO
dc.subjectContinuous renal replacement therapyes_CO
dc.subjectDialysises_CO
dc.subjectChildrenes_CO
dc.titleRegional citrate anticoagulation for continuous renal replacement therapy in childrenes_CO
dc.typearticleen
dc.type.hasVersionpublishedVersiones_CO
dc.rights.accessRightsopenAccesses_CO
dc.identifier.doi10.1007/s00467-016-3544-9


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 InternationalExcept where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International